Skip to main navigation Skip to search Skip to main content

Wilson's disease and the neuroleptic malignant syndrome

  • Peter Buckley
  • , Eamonn Carmody
  • , Michael Hutchinson

Research output: Contribution to journalArticlepeer-review

Abstract

Wilson's Disease (Hepatolenticular degeneration) is an uncommon disorder of copper metabolism, characterised by excessive copper deposition in the liver, brain and eyes. Psychiatric symptoms were prominent in eight of the twelve patients originally described by Wilson some 88 years ago1. Since then a wide range of psychiatric presentations have been documented including behavioural disturbances, affective psychoses, schizophrenia-like psychoses, intellectual deterioration and dementia.2'3 Here we describe a patient who presented with a psychiatric disturbance, was treated with neuroleptic medication and subsequently developed Neuroleptic Malignant Syndrome (NMS).

Original languageEnglish (US)
Pages (from-to)138-139
Number of pages2
JournalIrish Journal of Psychological Medicine
Volume7
Issue number2
DOIs
StatePublished - Sep 1990
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Hepatolenticular degeneration
  • Neuroleptic Malignant Syndrome

ASJC Scopus subject areas

  • Applied Psychology
  • Psychiatry and Mental health
  • History and Philosophy of Science

Fingerprint

Dive into the research topics of 'Wilson's disease and the neuroleptic malignant syndrome'. Together they form a unique fingerprint.

Cite this